Rhabdomyolysis without Hemolytic Crisis in a Juvenile Patient with Glucose-6-Phosphate Dehydrogenase Deficiency

2014

Closed access Metadata (CSL-JSON)
DOI 10.1055/s-0034-1390605
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Introduction: Glucose-6-phosphate dehydrogenase deficiency (G6PD) is a common X-linked inherited disorder affecting persons of African, Asian, Mediterranean, or Middle-Eastern descent. The erythrocytes of the patients express an increased vulnerability to oxidative stress. The majority of persons with reduced enzyme activity is asymptomatic, but some have episodic severe hemolysis and others chronic anemia. There are only a few reports of rhabdomyolysis during a hemolytic crisis and one case report of malignant hyperthermia during anesthesia. Case Report: A 17-year-old patient of Middle Eastern origin came to our hospital because of abdominal pain after sports and the ingestion of beans. He had normal hemoglobin and red cell blood count, but moderate thrombopenia, hyperbilirubinemia, and a creatine kinase (CK) of 6,939 U/L. During the next days, the CK went up to 21,753 U/L with extensive high myoglobin of more than 3,000 ng/mL. Lowest erythrocyte count was 4.47 T/L and lowest hemoglobin 13.9 g/dL. Muscle biopsy revealed augmented storage of glycogen. The whole-exome analysis by next generation sequencing (NGS) showed a hemizygous pathogen mutation in the exome 6 (c.563C>T; p.Ser188Phe) of the G6PD gene. Conclusion: In a patient with rhabdomyolysis even without substantial hemolysis, a G6PD should be considered. This diagnosis is essential advising the patient concerning medicine and substance use.